ECSP003314A - DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST - Google Patents

DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST

Info

Publication number
ECSP003314A
ECSP003314A ECSP003314A ECSP003314A EC SP003314 A ECSP003314 A EC SP003314A EC SP003314 A ECSP003314 A EC SP003314A EC SP003314 A ECSP003314 A EC SP003314A
Authority
EC
Ecuador
Prior art keywords
opioid
agonist
combination
formulations containing
drug formulations
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Johannes Heinrich Antonius Bartholomaus
Jurgen Betzing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003314 priority Critical patent/ECSP003314A/en
Publication of ECSP003314A publication Critical patent/ECSP003314A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulaciones medicamentosas retardadas que contienen una combinaciòn de un opioide o una sal fisiològicamente tolerable del mismo, un agonista o una sal fisiològicamente tolerable del mismo, conjuntamnete con lactosa o fosfato monoàcido càlcico, con o sin otros excipinetes farmacèuticos, asi como su uso en estados àlgicos de mediana intensidad hasta agudos severos o crtònicos.Delayed medicinal formulations containing a combination of an opioid or a physiologically tolerable salt thereof, an agonist or a physiologically tolerable salt thereof, together with lactose or calcium monoacid phosphate, with or without other pharmaceutical excipines, as well as its use in allergic states of medium intensity to severe or critical acute.

ECSP003314 2000-01-11 2000-01-11 DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST ECSP003314A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003314 ECSP003314A (en) 2000-01-11 2000-01-11 DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003314 ECSP003314A (en) 2000-01-11 2000-01-11 DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST

Publications (1)

Publication Number Publication Date
ECSP003314A true ECSP003314A (en) 2000-03-22

Family

ID=42040945

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003314 ECSP003314A (en) 2000-01-11 2000-01-11 DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST

Country Status (1)

Country Link
EC (1) ECSP003314A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700508B2 (en) 2010-05-10 2017-07-11 Euro-Celtique S.A. Pharmaceutical compositions comprising hydromorphone and naloxone
US9901540B2 (en) 2010-05-10 2018-02-27 Euro-Celtique S.A. Combination of active loaded granules with additional actives
US10076499B2 (en) 2006-08-25 2018-09-18 Purdue Pharma L.P. Tamper resistant dosage forms

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10076499B2 (en) 2006-08-25 2018-09-18 Purdue Pharma L.P. Tamper resistant dosage forms
US10076498B2 (en) 2006-08-25 2018-09-18 Purdue Pharma L.P. Tamper resistant dosage forms
US9700508B2 (en) 2010-05-10 2017-07-11 Euro-Celtique S.A. Pharmaceutical compositions comprising hydromorphone and naloxone
US9901540B2 (en) 2010-05-10 2018-02-27 Euro-Celtique S.A. Combination of active loaded granules with additional actives

Similar Documents

Publication Publication Date Title
AR022252A1 (en) ORAL ADMINISTRATION COMPOSITION.
EA199800946A1 (en) CONCENTRATED ANTIBODY PREPARATION
ES2162517T3 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND FIBRATE AND ITS USE IN THE PREPARATION OF DRUGS INTENDED TO REDUCE HYPERGLYCEMIA.
ATE286057T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING CLAVULANIC ACID
AR090677A2 (en) PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE
PT893992E (en) FORMS OF FAST DISINTEGRATION ORAL DOSAGE
ES2195638T3 (en) PREPARATIONS OF PHARMACEUTICAL COMBINATIONS IN SOLID FORM OF DOSAGE CONTAINING CARDEVILOL AND HYDROCLOROTIAZIDA.
SV2004001556A (en) ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY
AR042937A2 (en) SUSTAINED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGS
ES2190205T3 (en) COMBINATION FOR THE TREATMENT OF THE ALCOHOL DEPENDENCE CONTAINING AN OPIOID ANTAGONIST AND A NMDA RECEPTOR COMPLEX MODULATOR.
BR0012082A (en) Pharmaceutical formulation for administration comprising morphine and its use
DK0776202T3 (en) Liposomally encapsulated taxol, its preparation for its use
DE60131760D1 (en) DEVICE FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE ACTIVE IN POWDER FORM
DE60008374D1 (en) ANESTHETIC PREPARATION CONTAINING AN NMDA ANTAGONIST AND AN ALPHA-2 ADRENERGEN AGONIST
PT1112266E (en) SUBSTITUTED 4-AMINO-2-ARYL-PYRIMIDINES, ITS PREPARATION, ITS USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE69932510D1 (en) VASKULARISIERUNGSINHIBITOREN
DE50005529D1 (en) ORAL PHARMACEUTICAL FORMS FOR ADMINISTRATING A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
DK1112060T3 (en) Dosage form using liquid formulation
AR031761A1 (en) REPINOTANE KIT
NO20023551D0 (en) Ibuprofen-containing active agent preparation
CR6398A (en) 5HT1 ANTAGONISTS FOR ANTIDEPRESSIVE THERAPY
HN2003000115A (en) PHARMACEUTICAL FORMULATION THAT MELATONINE INCLUDES
ECSP003314A (en) DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST
DE59914183D1 (en) DISPOSABLE DEVICE FOR A COMPOSITION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
ATE401084T1 (en) STORAGE-Stable PHARMACEUTICAL PREPARATIONS CONTAINING TORASEMIDE